| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8211472 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 8 Pages |
Abstract
Using c-miRNA signature and clinical factors, we developed a DRS that identified a subset of patients with locally advanced NSCLC who derive an OS benefit from high-dose radiation therapy. This DRS may guide dose escalation in a patient-specific manner.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Yilun MS, Peter G. MD, PhD, Nan MD, PhD, Robert T. MD, Muneesh MD, PhD, Jason W.D. MD, James A. MD, MBA, Gregory P. MD, Theodore S. MD, PhD, Randall K. PhD, Martha M. PhD, Feng-Ming MD, PhD, Shruti MD, Matthew J. PhD,